Home › Neurologic Diseases › Michigan
Neurologic Diseases clinical trials in Michigan
7 studies for Neurologic Diseases are looking for participants at sites in Michigan.
Cities in Michigan
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Product Surveillance Registry
- Ann Arbor
- Bay City
- Lansing
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #002, Farmington Hills
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Ann Arbor
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- The University of Michigan, Ann Arbor
Recruiting
Ages 3 to 21 · All sexes · Updated Aug 19, 2026 · NCT05527652Ask Questions About Clinical Trials
- Karmanos Cancer Institute at McLaren Bay Region, Bay City
- Karmanos Cancer Institute at McLaren Clarkston, Clarkston
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- and 5 more
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07343297Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
Recruiting
Ages 60 and older · All sexes · Updated Jun 5, 2026 · NCT04179981From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.